Drugs: cardiovascular system

You have access
Diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline
David Liu, Erica Peterson, James Dooner, Mark Baerlocher, Leslie Zypchen, Joel Gagnon, Michael Delorme, Chad Kim Sing, Jason Wong, Randolph Guzman, Gavin Greenfield, Otto Moodley and Paul Yenson; for the Interdisciplinary Expert Panel on Iliofemoral Deep Vein Thrombosis (InterEPID)

CMAJ November 17, 2015 187 (17) 1288-1296; DOI: https://doi.org/10.1503/cmaj.141614
You have access
Diagnosis and management of acute ischemic stroke: speed is critical
Tapuwa D. Musuka, Stephen B. Wilton, Mouhieddin Traboulsi and Michael D. Hill

CMAJ September 08, 2015 187 (12) 887-893; DOI: https://doi.org/10.1503/cmaj.140355
You have access
Trimethoprim–sulfamethoxazole and risk of sudden death among patients taking spironolactone
Tony Antoniou, Simon Hollands, Erin M. Macdonald, Tara Gomes, Muhammad M. Mamdani and David N. Juurlink; for the Canadian Drug Safety and Effectiveness Research Network

CMAJ March 03, 2015 187 (4) E138-E143; DOI: https://doi.org/10.1503/cmaj.140816
You have access
Is there a clinically relevant interaction between clarithromycin and statins not metabolized by cytochrome P450 3A4?
Daniel S. Streetman and Stephen M. Stout

CMAJ February 17, 2015 187 (3) 163-165; DOI: https://doi.org/10.1503/cmaj.150030
You have access
Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4
Daniel Q. Li, Richard Kim, Eric McArthur, Jamie L. Fleet, David G. Bailey, David Juurlink, Salimah Z. Shariff, Tara Gomes, Muhammad Mamdani, Sonja Gandhi, Stephanie Dixon and Amit X. Garg

CMAJ February 17, 2015 187 (3) 174-180; DOI: https://doi.org/10.1503/cmaj.140950
You have access
Managing hypertension: evidence supporting the 2013/2014 recommendations of the Canadian Hypertension Education Program
Kaberi Dasgupta, Raj Padwal, Luc Poirier and Robert R. Quinn; on behalf of the Canadian Hypertension Education Program Scientific Summary Writing Group

CMAJ February 03, 2015 187 (2) 116-119; DOI: https://doi.org/10.1503/cmaj.131440
You have access
Regulatory decisions pertaining to aprotinin may be putting patients at risk
Paul C. Hébert, Dean A. Fergusson, Brian Hutton, C. David Mazer, Stephen Fremes, Morris Blajchman, Charles MacAdams, George Wells, Jim Robblee, Jean Bussières and Kevin Teoh; for the BART Investigators

CMAJ December 09, 2014 186 (18) 1379-1386; DOI: https://doi.org/10.1503/cmaj.131582
You have access
Five Things to Know About ...: Dextromethorphan abuse
Tony Antoniou and David N. Juurlink

CMAJ November 04, 2014 186 (16) E631; DOI: https://doi.org/10.1503/cmaj.131676
You have access
Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities
Heli Halava, Maarit Jaana Korhonen, Risto Huupponen, Soko Setoguchi, Jaana Pentti, Mika Kivimäki and Jussi Vahtera

CMAJ September 02, 2014 186 (12) E449-E456; DOI: https://doi.org/10.1503/cmaj.131807
You have access
What is your call?: Progressive thrombocytopenia after cardiac surgery in a 67-year-old man
Ilana Kopolovic and Theodore E. Warkentin

CMAJ September 02, 2014 186 (12) 929-933; DOI: https://doi.org/10.1503/cmaj.131449

Main menu

User menu

Search

Drugs: cardiovascular system

Pages

Content

Information for

About